Literature DB >> 2987240

Subunit structure of a high-affinity receptor for type beta-transforming growth factor. Evidence for a disulfide-linked glycosylated receptor complex.

J Massagué.   

Abstract

The structure of high-affinity receptors for type beta-transforming growth factor (beta TGF) has been examined by affinity labeling with 125I-beta TGF and disuccinimidyl suberate. The major receptor component labeled by 125I-beta TGF in mouse, rat, and chick fibroblasts migrated as a 280-290-kilodalton species on dodecyl sulfate-polyacrylamide electrophoresis gels in the presence of reductant, dithiothreitol. A larger (330-kilodalton) species was labeled in human fibroblasts, but comparative peptide mapping indicated a close structural relationship with receptors from mouse fibroblasts. In the absence of reductant, the affinity-labeled beta TGF receptor migrated in the gels as a larger disulfide-linked complex. The molecular mass calculated from the hydrodynamic properties of native nonreduced beta TGF receptors was 565 (mouse) or 615 kilodaltons (human). Other molecular parameters for the beta TGF receptor were: Stokes radius, 8.3-8.5 nm; sedimentation coefficient, 12.7-13.0 S; and frictional ratio, f/f0 = 1.4. The beta TGF receptor was solubilized under conditions in which the structural and ligand-binding properties of the native state were retained. beta TGF receptors solubilized from human, mouse, and chick cells interacted specifically with immobilized wheat germ agglutinin. These data suggest that the high affinity receptor for beta TGF in human, rodent, and avian fibroblasts is a disulfide-linked glycosylated 565-615-kilodalton complex with a 280-330-kilodalton subunit that contains the ligand-binding site. The oligomeric structure of the beta TGF receptor does not appear to be induced by receptor occupancy with the ligand.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987240

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Betaglycan has multiple binding sites for transforming growth factor-beta 1.

Authors:  S Kaname; E Ruoslahti
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

2.  Type beta transforming growth factor is an inhibitor of myogenic differentiation.

Authors:  J Massagué; S Cheifetz; T Endo; B Nadal-Ginard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Inhibitory action of transforming growth factor beta on endothelial cells.

Authors:  G Müller; J Behrens; U Nussbaumer; P Böhlen; W Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Regulation of intestinal epithelial cell growth by transforming growth factor type beta.

Authors:  J A Barnard; R D Beauchamp; R J Coffey; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

5.  Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion.

Authors:  R J Coffey; L J Kost; R M Lyons; H L Moses; N F LaRusso
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

6.  Expression of rat transforming growth factor alpha mRNA during development occurs predominantly in the maternal decidua.

Authors:  V K Han; E S Hunter; R M Pratt; J G Zendegui; D C Lee
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

7.  Ehrlich ascites tumor cells produce a transforming growth factor-beta (TGFbeta)-like activity but lack receptors with TGFbeta-binding capacity.

Authors:  A Elexpuru; J Martín-Nieto; A Jimenez; C Gómez; A Villalobo
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

8.  The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line.

Authors:  E Helseth; G Unsgaard; A Dalen; R Vik
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

9.  Characterization of a human hepatoma cell line with acquired resistance to growth inhibition by transforming growth factor beta 1 (TGF-beta 1).

Authors:  K Hasegawa; Z Wang; M Inagaki; B I Carr
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

10.  Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase.

Authors:  D J Grainger; P R Kemp; C M Witchell; P L Weissberg; J C Metcalfe
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.